← All claims

Supplements · Metabolic & Cardiometabolic

garlic decreases blood pressure

In plain terms: Does garlic lower blood pressure?

Strong support Supplements 🔬 Includes disconfirming

Part of: 🧪 Garlic

RefutedContestedStrong support
consensus score 0.95

Yes, modestly — and mainly if your blood pressure is already high. Several meta-analyses show garlic drops systolic pressure by roughly 5–9 mmHg in people with hypertension, but little in those with normal pressure. It's a mild helper, not a replacement for medication.

Evidence ladder

How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."

Top evidence so far: All trials, pooled (Meta-analysis)

MechanismIn-vitroAnimalObservationalRCTMeta-analysis

How the studies fall

12 support 0 contradict 1 tested null 0 mixed · 13 sources, 8 independent groups

What the evidence shows

Garlic (esp. aged garlic extract) modestly lowers blood pressure, with the effect concentrated in people who already have hypertension; normotensive subgroups show little to no change. Three independent meta-analyses agree on direction.

The evidence (13)

SourceGradeStanceQualityFinding
Ziaei S et al.
2001 · Eur J Obstet Gynecol Reprod Biol
RCT tested-null moderate RCT n=100 preeclampsia-risk pregnant women: garlic 800mg - NO significant SBP/DBP/MAP difference (different population).
Wang HP et al.
2015 · J Clin Hypertens
meta-analysis supports high Meta 17 RCTs: SBP -3.75 / DBP -3.39 mmHg; significant SBP drop only in hypertensives (-4.4), not normotensives.
Sobenin IA et al.
2009 · Hypertens Res
RCT supports moderate RCT n=84: time-released Allicor SBP -7.0/DBP -3.8; Kwai SBP -5.4 (DBP ns).
Kwak JS et al.
2014 · Nutr Res Pract
meta-analysis supports moderate Meta 9-10 trials: garlic powder SBP -4.34/DBP -2.36 mmHg (mixed population).
Ried K
2016 · J Nutr
meta-analysis supports high Meta-analysis 20 RCTs (n=970): SBP -5.1 / DBP -2.5 mmHg overall; hypertensive subgroup -8.7 / -6.1 mmHg.
Ried K et al.
2010 · Maturitas
RCT supports moderate RCT n=50 treated-uncontrolled hypertensives: AGE 960mg SBP -10.2 mmHg if baseline SBP>=140. (Ried network.)
Xiong XJ et al.
2015 · Phytomedicine
meta-analysis supports moderate Meta 7 RCTs (hypertensives): SBP -6.71/DBP -4.79 mmHg.
Ried K et al.
2012 · Eur J Clin Nutr
RCT supports moderate Dose-response RCT n=79 uncontrolled hypertensives: 2-cap AGE SBP -11.8 mmHg; 1-cap not significant. (Ried network.)
Rohner A et al.
2015 · Am J Hypertens
meta-analysis supports moderate Meta 9 trials (hypertensives): SBP -9.1/DBP -3.8 mmHg; effect shrank in higher-quality sensitivity analysis. (Ried network.)
Serrano JCE et al.
2023 · Nutrients
RCT supports moderate Triple-blind RCT, Grade-I hypertensives on drugs: aged black garlic gave a small -1.8 / -1.5 mmHg extra reduction (clinically marginal); no endothelial/inflammatory change.
Ried K et al.
2008 · BMC Cardiovasc Disord
meta-analysis supports high Meta 11 RCTs: SBP -4.6 overall; hypertensive subgroup -8.4/-7.3 mmHg. (Ried network.)
Silagy CA, Neil HA
1994 · J Hypertens
meta-analysis supports moderate Earliest meta (8 RCTs, Kwai powder): modest BP reduction but authors judged evidence insufficient for routine clinical use - cautious positive.
Reinhart KM et al.
2008 · Ann Pharmacother
meta-analysis supports high Meta 10 trials: elevated-SBP subgroup SBP -16.3/DBP -9.3 mmHg; no effect if BP not elevated.

Disagree, or know a study we missed?

We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.

📚 Suggest a study ⚑ Flag / request reclassification

Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).

Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.